Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

11.09.2017

5 AJR Am J Roentgenol
2 Am J Clin Pathol
1 Ann Oncol
1 Ann Surg Oncol
11 Anticancer Res
3 BMC Cancer
3 Breast Cancer Res
8 Breast Cancer Res Treat
1 Breast J
2 Cancer
1 Cancer Chemother Pharmacol
5 Cancer Epidemiol Biomarkers Prev
1 Cancer Res
3 Clin Breast Cancer
1 Clin Cancer Res
3 Eur J Cancer
1 Int J Cancer
2 Int J Radiat Oncol Biol Phys
1 Lancet Oncol
1 Nat Rev Clin Oncol
2 Nature
1 NPJ Breast Cancer
7 PLoS One



    AJR Am J Roentgenol

  1. SEIDENWURM D, Breslau J
    Finding the Best Recall and Cancer Detection Rates for Screening Mammography.
    AJR Am J Roentgenol. 2017;209:W110.
    >> Share

  2. GEORGIAN-SMITH D
    Screening Mammography: Effect of Recall Rates by Population Type and Acknowledgement of Founding Father Myron Moskowitz.
    AJR Am J Roentgenol. 2017;209:W197.
    >> Share

  3. HOOLEY RJ, Philpotts LE
    Reply to "Digital Breast Tomosynthesis Assists in Differentiating Vascular Calcification From Malignant Calcification".
    AJR Am J Roentgenol. 2017;209:W116.
    >> Share

  4. COHEN Y
    Digital Breast Tomosynthesis Assists in Differentiating Vascular Calcification From Malignant Calcification.
    AJR Am J Roentgenol. 2017;209:W115.
    >> Share

  5. GRABLER P, Ansell DA
    Reply to "Finding the Best Recall and Cancer Detection Rates for Screening Mammography".
    AJR Am J Roentgenol. 2017;209:W111.
    >> Share


    Am J Clin Pathol

  6. KUBA MG, Lester SC, Giess CS, Bertagnolli MM, et al
    Fibromatosis of the Breast: Diagnostic Accuracy of Core Needle Biopsy.
    Am J Clin Pathol. 2017;148:243-250.
    >> Share

  7. LIN CY, Carneal EE, Lichtensztajn DY, Gomez SL, et al
    Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks.
    Am J Clin Pathol. 2017;148:199-207.
    >> Share


    Ann Oncol


  8. Appendix 2: Advanced breast cancer: MCBS eUpdate published online 25 April 2017 (www.esmo.org/Guidelines/Breast-Cancer).
    Ann Oncol. 2017;28.
    >> Share


    Ann Surg Oncol

  9. ONG CT, Thomas SM, Blitzblau RC, Fayanju OM, et al
    Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011.
    Ann Surg Oncol. 2017 Sep 6. doi: 10.1245/s10434-017-6075.
    >> Share


    Anticancer Res

  10. FANG QI, Wang X, Luo G, Yu M, et al
    Increased CXCL8 Expression Is Negatively Correlated with the Overall Survival of Patients with ER-Negative Breast Cancer.
    Anticancer Res. 2017;37:4845-4852.
    >> Share

  11. KUBAN-JANKOWSKA A, Sahu KK, Gorska-Ponikowska M, Tuszynski JA, et al
    Inhibitory Activity of Iron Chelators ATA and DFO on MCF-7 Breast Cancer Cells and Phosphatases PTP1B and SHP2.
    Anticancer Res. 2017;37:4799-4806.
    >> Share

  12. KIM D, Radin D, Leonardi D
    Probing the Molecular Mechanisms Governing the Oncolytic Activity of Paeonia suffruticosa on Triple-negative Breast Cancer Cells In Vitro.
    Anticancer Res. 2017;37:4813-4819.
    >> Share

  13. TIMMER M, Werner JM, Rohn G, Ortmann M, et al
    Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by Hormone Therapy.
    Anticancer Res. 2017;37:4859-4865.
    >> Share

  14. KORASHY HM, Maayah ZH, Al Anazi FE, Alsaad AM, et al
    Sunitinib Inhibits Breast Cancer Cell Proliferation by Inducing Apoptosis, Cell-cycle Arrest and DNA Repair While Inhibiting NF-kappaB Signaling Pathways.
    Anticancer Res. 2017;37:4899-4909.
    >> Share

  15. CHOU AK, Hsiao CL, Shih TC, Wang HC, et al
    The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes in Breast Cancer in Taiwan.
    Anticancer Res. 2017;37:4973-4977.
    >> Share

  16. PAN E, Tung L, Ragab O, Morocco E, et al
    Inflammatory Breast Cancer Outcomes in a Contemporary Series.
    Anticancer Res. 2017;37:5057-5063.
    >> Share

  17. WAKAHARA M, Sakabe T, Kubouchi Y, Hosoya K, et al
    Subcellular Localization of Maspin Correlates with Histone Deacetylase 1 Expression in Human Breast Cancer.
    Anticancer Res. 2017;37:5071-5077.
    >> Share

  18. RICCIARDI E, Tomao F, Aletti G, Bazzurini L, et al
    Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series.
    Anticancer Res. 2017;37:5241-5248.
    >> Share

  19. YAMASHITA N, Tokunaga E, Yamamoto H, Shimizu C, et al
    The Local Recurrence of Breast Cancer with Squamous Metaplasia and Obvious Histological Heterogeneity.
    Anticancer Res. 2017;37:5249-5254.
    >> Share

  20. KRAMMER J, Stepniewski K, Kaiser CG, Brade J, et al
    Value of Additional Digital Breast Tomosynthesis for Preoperative Staging of Breast Cancer in Dense Breasts.
    Anticancer Res. 2017;37:5255-5261.
    >> Share


    BMC Cancer

  21. WENNERS A, Grambach J, Koss J, Maass N, et al
    Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.
    BMC Cancer. 2017;17:632.
    >> Share

  22. HALLAMIES S, Pelttari LM, Poikonen-Saksela P, Jekunen A, et al
    CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.
    BMC Cancer. 2017;17:620.
    >> Share

  23. GOLDVASER H, Gal O, Rizel S, Hendler D, et al
    The association between smoking and breast cancer characteristics and outcome.
    BMC Cancer. 2017;17:624.
    >> Share


    Breast Cancer Res

  24. ALI MA, Czene K, Eriksson L, Hall P, et al
    Breast Tissue Organisation and its Association with Breast Cancer Risk.
    Breast Cancer Res. 2017;19:103.
    >> Share

  25. LEGARE S, Chabot C, Basik M
    SPEN, a new player in primary cilia formation and cell migration in breast cancer.
    Breast Cancer Res. 2017;19:104.
    >> Share

  26. MORI H, Chen JQ, Cardiff RD, Penzvalto Z, et al
    Pathobiology of the 129:Stat1 -/- mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotype.
    Breast Cancer Res. 2017;19:102.
    >> Share


    Breast Cancer Res Treat

  27. GALLARDO A, Garcia-Valdecasas B, Murata P, Teran R, et al
    Inverse relationship between Ki67 and survival in early luminal breast cancer: confirmation in a multivariate analysis.
    Breast Cancer Res Treat. 2017 Sep 1. doi: 10.1007/s10549-017-4486.
    >> Share

  28. DREYER MS, Nattinger AB, McGinley EL, Pezzin LE, et al
    Socioeconomic status and breast cancer treatment.
    Breast Cancer Res Treat. 2017 Sep 7. doi: 10.1007/s10549-017-4490.
    >> Share

  29. CORTES J, Rugo HS, Awada A, Twelves C, et al
    Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.
    Breast Cancer Res Treat. 2017 Sep 7. doi: 10.1007/s10549-017-4482.
    >> Share

  30. THOMAS R, Rowell R, Crichton S, Cain H, et al
    An observational study investigating failure of primary endocrine therapy for operable breast cancer in the elderly.
    Breast Cancer Res Treat. 2017 Sep 6. doi: 10.1007/s10549-017-4494.
    >> Share

  31. ALTUNDAG K
    Predictive role of loco-regional radiotherapy among metastatic breast cancer patients who had undergone primary tumor surgery.
    Breast Cancer Res Treat. 2017 Sep 5. doi: 10.1007/s10549-017-4493.
    >> Share

  32. VAN MACKELENBERGH MT, Denkert C, Nekljudova V, Karn T, et al
    Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials.
    Breast Cancer Res Treat. 2017 Sep 5. doi: 10.1007/s10549-017-4480.
    >> Share

  33. MARTINEZ ME, Gomez SL, Tao L, Cress R, et al
    Erratum to: Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women.
    Breast Cancer Res Treat. 2017 Sep 4. doi: 10.1007/s10549-017-4455.
    >> Share

  34. ALENZI EO, Madhavan SS, Tan X
    Association of the severity of diabetes-related complications with stage of breast cancer at diagnosis among elderly women with pre-existing diabetes.
    Breast Cancer Res Treat. 2017 Sep 2. doi: 10.1007/s10549-017-4477.
    >> Share


    Breast J

  35. YANG YL, Qian XL, Fu L
    Comparison of HER2 status of breast cancer between Chinese women in China and Chinese-American women in the US.
    Breast J. 2017 Sep 6. doi: 10.1111/tbj.12921.
    >> Share


    Cancer


  36. More breast cancer patients could benefit from PARP inhibitors.
    Cancer. 2017;123:3433.
    >> Share

  37. STURGEON KM, Hackley R, Fornash A, Dean LT, et al
    Strategic recruitment of an ethnically diverse cohort of overweight survivors of breast cancer with lymphedema.
    Cancer. 2017 Sep 7. doi: 10.1002/cncr.30935.
    >> Share


    Cancer Chemother Pharmacol

  38. TAGAWA N, Sugiyama E, Tajima M, Sasaki Y, et al
    Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer.
    Cancer Chemother Pharmacol. 2017 Sep 1. doi: 10.1007/s00280-017-3425.
    >> Share


    Cancer Epidemiol Biomarkers Prev

  39. ENGMANN NJ, Ergas IJ, Yao S, Kwan ML, et al
    Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study.
    Cancer Epidemiol Biomarkers Prev. 2017;26:1466-1469.
    >> Share

  40. ELLINGJORD-DALE M, Vos L, Hjerkind KV, Hjartaker A, et al
    Alcohol, physical activity, smoking and breast cancer subtypes in a large nested case-control study from the Norwegian Breast Cancer Screening Program.
    Cancer Epidemiol Biomarkers Prev. 2017 Sep 6. pii: cebp.0611.2017.
    >> Share

  41. LACSON JCA, Ma H, Lee E, Neuhausen SL, et al
    Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study.
    Cancer Epidemiol Biomarkers Prev. 2017;26:1462-1465.
    >> Share

  42. BIERMANN J, Nemes S, Parris TZ, Engqvist H, et al
    A novel 18-marker panel predicting clinical outcome in breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2017 Sep 6. pii: cebp.0606.2017.
    >> Share

  43. MORMILE R
    Gestational Diabetes Mellitus and Incident Invasive Breast Cancer-Letter.
    Cancer Epidemiol Biomarkers Prev. 2017;26:1474.
    >> Share


    Cancer Res

  44. METZGER E, Stepputtis SS, Strietz J, Preca BT, et al
    KDM4 inhibition targets breast cancer stem-like cells.
    Cancer Res. 2017 Sep 7. pii: canres.1754.2017.
    >> Share


    Clin Breast Cancer

  45. ZHOU J, Guo FJ, Hao XP, Chen CJ, et al
    Use of Breast Magnetic Resonance Imaging and Ultrasonography for Identifying Nonpalpable Axillae Metastases in Newly Diagnosed Breast Cancer Patients.
    Clin Breast Cancer. 2017 Aug 9. pii: S1526-8209(17)30348.
    >> Share

  46. MOUNSEY LA, Deal AM, Keith KC, Benbow JM, et al
    Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
    Clin Breast Cancer. 2017 Aug 9. pii: S1526-8209(17)30036.
    >> Share

  47. BATISTATOU A, Kotoula V, Bobos M, Kouvatseas G, et al
    Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.
    Clin Breast Cancer. 2017 Jul 13. pii: S1526-8209(17)30138.
    >> Share


    Clin Cancer Res

  48. MA CX, Suman V, Goetz MP, Northfelt DW, et al
    A Phase II trial of neoadjuvant MK2206, an AKT inhibitor, with anastrozole in clinical stage 2 or 3 PIK3CA mutant ER positive and HER2 negative breast cancer.
    Clin Cancer Res. 2017 Sep 5. pii: clincanres.1260.2017.
    >> Share


    Eur J Cancer

  49. PHI XA, Houssami N, Hooning MJ, Riedl CC, et al
    Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis.
    Eur J Cancer. 2017;85:31-38.
    >> Share

  50. PULITI D, Bucchi L, Mancini S, Paci E, et al
    Corrigendum to "Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy" [Eur J Cancer 75 (April 2017) 109-116].
    Eur J Cancer. 2017 Sep 2. pii: S0959-8049(17)31218.
    >> Share

  51. LIGHTOWLERS SV, Boersma LJ, Fourquet A, Kirova YM, et al
    Preoperative breast radiation therapy: Indications and perspectives.
    Eur J Cancer. 2017;82:184-192.
    >> Share


    Int J Cancer

  52. LAGENDIJK M, van Maaren MC, Saadatmand S, Strobbe LJ, et al
    Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.
    Int J Cancer. 2017 Sep 7. doi: 10.1002/ijc.31034.
    >> Share


    Int J Radiat Oncol Biol Phys

  53. RAHIMY E, Hong JC, Gross CP, Hu X, et al
    Increased Number of Beam Angles Is Associated With Higher Cardiac Dose in Adjuvant Fixed Gantry Intensity Modulated Radiation Therapy of Left-Sided Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Jun 27. pii: S0360-3016(17)33517.
    >> Share

  54. BRACKSTONE M, Palma D, Tuck AB, Scott L, et al
    Concurrent Neoadjuvant Chemotherapy and Radiation Therapy in Locally Advanced Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Jun 20. pii: S0360-3016(17)31054.
    >> Share


    Lancet Oncol

  55. EICHBAUM MHR, Kissel N, Neunhoeffer T, Dollas L, et al
    Hypoglossal paresis caused by a solitary breast cancer metasasis at the basal skull.
    Lancet Oncol. 2017;18:e552.
    >> Share


    Nat Rev Clin Oncol

  56. KILLOCK D
    Breast cancer: Short-term NAT reveals resistance.
    Nat Rev Clin Oncol. 2017 Sep 5. doi: 10.1038/nrclinonc.2017.
    >> Share


    Nature

  57. CALLAWAY E
    The trickiest family tree in biology.
    Nature. 2017;547:20-22.
    >> Share

  58. ABDERRAHMAN B, Jordan VC
    Angela M. Hartley Brodie (1934-2017).
    Nature. 2017;548:32.
    >> Share


    NPJ Breast Cancer

  59. VAYSSE C, Lomo J, Garred O, Fjeldheim F, et al
    Erratum: Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer.
    NPJ Breast Cancer. 2017;3:35.
    >> Share


    PLoS One

  60. WEN Y, Chen Z, Lu J, Ables E, et al
    Quantitative analysis and comparison of 3D morphology between viable and apoptotic MCF-7 breast cancer cells and characterization of nuclear fragmentation.
    PLoS One. 2017;12:e0184726.
    >> Share

  61. CHENG SH, Huang TT, Cheng YH, Tan TBK, et al
    Validation of the 18-gene classifier as a prognostic biomarker of distant metastasis in breast cancer.
    PLoS One. 2017;12:e0184372.
    >> Share

  62. PELAEZ-GARCIA A, Yebenes L, Berjon A, Angulo A, et al
    Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.
    PLoS One. 2017;12:e0183452.
    >> Share

  63. CHANDLER MR, Keene KS, Tuomela JM, Forero-Torres A, et al
    Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
    PLoS One. 2017;12:e0183832.
    >> Share

  64. KWIECIEN JM, Bassey-Archibong BI, Dabrowski W, Rayner LG, et al
    Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis.
    PLoS One. 2017;12:e0183883.
    >> Share

  65. ETTL J, Klein E, Hapfelmeier A, Grosse Lackmann K, et al
    Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1.
    PLoS One. 2017;12:e0183917.
    >> Share

  66. SCHULTZ DJ, Muluhngwi P, Alizadeh-Rad N, Green MA, et al
    Genome-wide miRNA response to anacardic acid in breast cancer cells.
    PLoS One. 2017;12:e0184471.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016